Healthcare -
Biotechnology - NASDAQ - US
$ 1.65
2.48 %
$ 99.1 M
Market Cap
-1.2
P/E
ABOS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ABOS - Acumen Pharmaceuticals, Inc.
152 M
LAST VALUE
-12.99%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR